Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801359200 on February 21, 2008

J. Biol. Chem., Vol. 283, Issue 16, 11064-11071, April 18, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/16/11064    most recent
M801359200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchiya, H.
Right arrow Articles by Sugimoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchiya, H.
Right arrow Articles by Sugimoto, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Prostaglandin E2 Attenuates Preoptic Expression of GABAA Receptors via EP3 Receptors*

Hiroyoshi Tsuchiya{ddagger}1, Takakazu Oka§, Kazuhiro Nakamura||2, Atsushi Ichikawa{ddagger}, Clifford B. Saper§, and Yukihiko Sugimoto{ddagger}3

From the {ddagger}Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences and ||Laboratory of Molecular Neurobiology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan, §Department of Neurology and Program in Neuroscience, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, and Division of Psychosomatic Medicine, Department of Neurology, University of Occupational and Environmental Health, Iseigaoka 1-1, Yahatanishi-ku, Kitakyushu, 807-8555, Japan

Prostaglandin E2 (PGE2) has been shown to produce fever by acting on EP3 receptors within the preoptic area of the brain. However, there is little information about the molecular events downstream of EP3 activation in preoptic neurons. As a first step toward this issue, we examined PGE2-induced gene expression changes at single-cell resolution in preoptic neurons expressing EP3. Brain sections of the preoptic area from PGE2- or saline-injected rats were stained with an anti-EP3 antibody, and the cell bodies of EP3-positive neurons were dissected and subjected to RNA amplification procedures. Microarray analysis of the amplified products demonstrated the possibility that gene expression of {gamma}-aminobutyric acid type A (GABAA) receptor subunits is decreased upon PGE2 injection. Indeed, we found that most EP3-positive neurons in the mouse preoptic area are positive for the {alpha}2 or {gamma}2 GABAA receptor subunit. Moreover, PGE2 decreased the preoptic gene expression of these GABAA subunits via an EP3-dependent and pertussis toxin-sensitive pathway. PGE2 also attenuated the preoptic protein expression of the {alpha}2 subunit in wild-type but not in EP3-deficient mice. These results indicate that PGE2-EP3 signaling elicits Gi/o activation in preoptic thermocenter neurons, and we propose the possibility that a rapid decrease in preoptic GABAA expression may be involved in PGE2-induced fever.


Received for publication, February 20, 2008

* This work was supported in part by a grant from the Sankyo Foundation of Life Science and by grants-in-aid for scientific research (B) and on priority areas (Applied Genomics, Mechanisms of Sex Differentiation, and Molecular Brain Science) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Ministry of Health and Labor of Japan, respectively. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.

2 Supported by a fellowship from the Japan Society for the Promotion of Science.

3 To whom correspondence should be addressed: Kyoto University Graduate School of Pharmaceutical Sciences, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. Fax: 81-75-753-4557; E-mail: ysugimot{at}pharm.kyoto-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement